Single logo
LoginSign Up

GDP Counterfeit Product Detection and Prevention Audit Checklist

A specialized checklist for auditing GDP compliance in pharmaceutical counterfeit detection and prevention, focusing on supplier verification, authentication technologies, staff training, and incident response procedures.

GDP Counterfeit Product Detection and Prevention Audit Checklist

by: audit-now
4.2

Get Template

About This Checklist

Detecting and preventing counterfeit products is a critical aspect of Good Distribution Practice (GDP) in the pharmaceutical industry. This comprehensive GDP Counterfeit Product Detection and Prevention Audit Checklist is designed to help pharmaceutical companies evaluate and enhance their processes for identifying, reporting, and mitigating the risks of counterfeit products entering the legitimate supply chain. By focusing on key areas such as supplier verification, product authentication technologies, staff training, and incident response procedures, this checklist enables auditors to thoroughly assess compliance with GDP requirements for safeguarding product integrity. Regular use of this checklist can significantly improve the security of the pharmaceutical supply chain, protect patient safety, and ensure the authenticity of distributed products.

Learn more

Industry

Healthcare

Standard

GDP - Good Distribution Practice

Workspaces

Pharmaceutical Distribution Centers

Occupations

Quality Assurance Manager
Supply Chain Security Specialist
Regulatory Affairs Officer
Procurement Manager
Forensic Analyst
1
Is there a process in place for verifying suppliers of pharmaceutical products?
2
What is the average response time for incidents related to counterfeit products?
Min: 0
Target: 24
Max: 72
3
Describe the anti-counterfeiting measures implemented in the distribution center.
4
Have all relevant staff completed training on counterfeit prevention?
5
What procedures are in place to ensure product integrity during storage and transportation?
6
What authentication technology is utilized to verify pharmaceutical products?
7
Are regular audits conducted to assess authentication processes?
8
What is the percentage of counterfeit products detected in the last year?
Min: 0
Target: 5
Max: 100
9
Describe the procedure for reporting incidents of counterfeit product detection.
10
When was the last training on product authentication conducted for staff?
11
What security measures are implemented in the supply chain?
12
Provide a summary of the latest risk assessment related to supply chain security.
13
How often are security audits conducted in the supply chain?
Min: 0
Target: 6
Max: 12
14
Is there an incident response plan in place for supply chain security breaches?
15
Describe the process for verifying supplier compliance with security standards.
16
How frequently are product integrity checks conducted?
17
Outline the protocols in place to ensure patient safety during the distribution of products.
18
How many incidents of product tampering were reported in the last year?
Min: 0
Target: 2
Max: 100
19
Has emergency response training been completed by all relevant staff?
20
When was the last review of patient safety protocols conducted?
21
What methodology is used for conducting risk assessments related to counterfeiting?
22
Is there a documented risk management plan specifically addressing counterfeit risks?
23
How many hours of training have been provided to staff on counterfeit risk management?
Min: 0
Target: 10
Max: 100
24
Provide a summary of past incidents related to counterfeit products within the organization.
25
When was the risk management plan last updated?

FAQs

Supplier verification should include thorough background checks, assessment of GDP compliance, verification of regulatory licenses, and ongoing monitoring of supplier performance and product quality.

Authentication technologies can include serialization, 2D barcodes, holograms, tamper-evident seals, and blockchain-based track-and-trace systems to verify product authenticity throughout the supply chain.

Staff training should cover identification of suspicious products, common counterfeiting techniques, proper use of authentication tools, reporting procedures for suspected counterfeits, and the importance of supply chain integrity.

This checklist provides a framework for evaluating the comprehensiveness of incident response plans, including steps for product quarantine, investigation, reporting to authorities, and communication with stakeholders.

Assessment should include examination of packaging quality, print clarity, batch number and expiry date consistency, presence and integrity of security features, and comparison with authenticated reference samples.

Benefits of GDP Counterfeit Product Detection and Prevention Audit Checklist

Ensures comprehensive evaluation of counterfeit prevention measures in the distribution chain

Helps identify vulnerabilities in current anti-counterfeiting processes

Facilitates compliance with GDP requirements for product authentication and traceability

Improves overall supply chain security and product integrity

Supports patient safety by reducing the risk of counterfeit products reaching consumers